MX9806209A - Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion. - Google Patents

Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.

Info

Publication number
MX9806209A
MX9806209A MX9806209A MX9806209A MX9806209A MX 9806209 A MX9806209 A MX 9806209A MX 9806209 A MX9806209 A MX 9806209A MX 9806209 A MX9806209 A MX 9806209A MX 9806209 A MX9806209 A MX 9806209A
Authority
MX
Mexico
Prior art keywords
threo
epimerisation
recycling
preparation
enantiomers
Prior art date
Application number
MX9806209A
Other languages
English (en)
Other versions
MX209701B (es
Inventor
Marianne Langston
Hooshang Shahriari Zavareh
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602174.6A external-priority patent/GB9602174D0/en
Priority claimed from GBGB9618836.2A external-priority patent/GB9618836D0/en
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Publication of MX9806209A publication Critical patent/MX9806209A/es
Publication of MX209701B publication Critical patent/MX209701B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0004—Crystallisation cooling by heat exchange
    • B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un proceso para mantener un enantiomero individual, d o 1, de treo-metilfenidato, comprende la resolucion de la mezcla de los enantiomeros; la racemizacion del enantiomero no deseado para dar una mezcla de los cuatro esteroisomeros; y la separacion de los esteroisomeros eritro para dejar la mezcla para resolucion.
MX9806209A 1996-02-02 1998-07-31 Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion. MX209701B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602174.6A GB9602174D0 (en) 1996-02-02 1996-02-02 Resolution/racemization process
GBGB9618836.2A GB9618836D0 (en) 1996-09-10 1996-09-10 Resolution/racemisation process

Publications (2)

Publication Number Publication Date
MX9806209A true MX9806209A (es) 1998-10-31
MX209701B MX209701B (es) 2002-08-15

Family

ID=26308593

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9806209A MX209701B (es) 1996-02-02 1998-07-31 Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.

Country Status (16)

Country Link
US (1) US7164025B2 (es)
EP (1) EP0879228B1 (es)
JP (1) JP2000504008A (es)
KR (1) KR100453707B1 (es)
AT (1) ATE226940T1 (es)
AU (1) AU715183B2 (es)
CA (1) CA2243534C (es)
CZ (1) CZ292609B6 (es)
DE (1) DE69716713T2 (es)
DK (1) DK0879228T3 (es)
ES (1) ES2187753T3 (es)
HU (1) HUP9901658A3 (es)
MX (1) MX209701B (es)
PT (1) PT879228E (es)
SK (1) SK283553B6 (es)
WO (1) WO1997028124A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
GB9700912D0 (en) * 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6100401A (en) * 1998-04-20 2000-08-08 Novartris Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US6025502A (en) * 1999-03-19 2000-02-15 The Trustees Of The University Of Pennsylvania Enantopselective synthesis of methyl phenidate
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
US7897777B2 (en) * 2007-01-05 2011-03-01 Archimica, Inc. Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate
US20130310422A1 (en) 2010-09-01 2013-11-21 The General Hospital Corporation Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
ES2883589T3 (es) 2011-03-23 2021-12-09 Ironshore Pharmaceuticals & Dev Inc Procedimientos y composiciones para el tratamiento del trastorno de déficit de atención
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
SU466229A1 (ru) * 1973-01-23 1975-04-05 Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе Способ получени гидрохлорида метилового эфира трео- -фенил- (пиперидил-2)-уксусной кислоты
US4254261A (en) * 1979-10-15 1981-03-03 Merck & Co., Inc. Dehydroabietylammonium salts of 6-oxo-2-piperidinecarboxylic acid
US5733756A (en) * 1996-01-05 1998-03-31 Celgene Corporation Lactams and processes for stereoselective enrichment of lactams, amides, and esters
MX9805870A (es) * 1996-01-22 1999-01-31
US6242464B1 (en) * 1996-01-22 2001-06-05 Chiroscience Limited Single isomer methylphenidate and resolution process
GB9604943D0 (en) * 1996-03-08 1996-05-08 Chiroscience Ltd Resolution

Also Published As

Publication number Publication date
SK283553B6 (sk) 2003-09-11
ATE226940T1 (de) 2002-11-15
AU715183B2 (en) 2000-01-20
EP0879228A1 (en) 1998-11-25
DE69716713D1 (de) 2002-12-05
MX209701B (es) 2002-08-15
KR19990082186A (ko) 1999-11-25
DE69716713T2 (de) 2003-07-03
EP0879228B1 (en) 2002-10-30
ES2187753T3 (es) 2003-06-16
CZ227598A3 (cs) 1998-12-16
CZ292609B6 (cs) 2003-11-12
AU1608297A (en) 1997-08-22
KR100453707B1 (ko) 2005-01-25
WO1997028124A1 (en) 1997-08-07
US20020032335A1 (en) 2002-03-14
PT879228E (pt) 2003-01-31
SK97998A3 (en) 1999-01-11
CA2243534A1 (en) 1997-08-07
US7164025B2 (en) 2007-01-16
CA2243534C (en) 2003-08-26
DK0879228T3 (da) 2003-03-03
HUP9901658A2 (hu) 1999-09-28
HUP9901658A3 (en) 1999-12-28
JP2000504008A (ja) 2000-04-04

Similar Documents

Publication Publication Date Title
MX9806209A (es) Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion.
IE891859L (en) New enantiomers and their isolation
MY121543A (en) Preparation of 3,4,4-trisubstituted-piperidinyl-n- alkylcarboxylates and intermediates
HU9701652D0 (en) Process for producing l-amino acid through fermentation
EP0670370A3 (en) Process for the preparation of glutamic acid by fermentation.
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
AU2102497A (en) Resolution of threo-methylphenidate
MY116593A (en) Process for the preparation of o-demethyltramadol enantiomers
HUP9900149A3 (en) Process for producing l-lysine by fermentation
EP1004671A4 (en) METHOD FOR THE PRODUCTION OF L-GLUTAMIC ACID BY FERMENTATION
MX9708013A (es) Procedimiento para preparar 1-(piridil)-2-ciclohexil-amina racemica y enantiomera.
AU6578400A (en) Novel method for preparing benzoperhydroisoindole compounds
HUP9801083A3 (en) Process for producing (15,4r)- or (1r,4s)-4-[(2-amino-6-chloro-9h-purin)-9-yl]-2-cyclopentene-1-methanol
AU1319697A (en) Process for producing oleanolic acid analogs by culturing hairy root
UA48993C2 (uk) СПОСІБ ОТРИМАННЯ N-АЦЕТИЛ-(L)-4-ЦІАНОФЕНІЛАЛАНІНУ Аc-(L)-Phe(4-CN)-OH І N-АЦЕТИЛ-(L)-П-АМІДИНФЕНІЛАЛАНІН-ЦИКЛОГЕКСИЛГЛІЦИН-<font face="Symbol">b</font>-(3-N-МЕТИЛПІРИДИН)-АЛАНІНУ Аc-(L)-pАph-Сhg-PalMe(3)-NH<sub>2</sub>
WO1998009601A3 (en) Process to prepare pharmaceutical compounds
ZA954518B (en) Method of producing l-lysine by fermentation

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees